Back to search

University of Adelaide

A combined lipophilic prodrug and lipid-based drug delivery approach to enable oral chemotherapy (with SN38)

Abstract

dc:description.abstract

The current project is focused on enabling the oral delivery of a challenging, but highly potent compound against CRC, 7-ethyl-10-hydroxycamptothecin (SN38), using nanomedicine and/or prodrug approaches. In particular, the thesis describes (i) the fabrication of a silica-lipid hybrid (SLH) delivery systems for SN38, with high drug loading by drug-surfactant complexation and determination of its in vitro and in vivo performance; (ii) the synthesis, characterisation and lead selection of lipophilic prodrugs for SN38; and (iii) the development of a lipid-based oral delivery system for the lead lipophilic SN38 prodrug.

Degree

thesis:*
College dc:contributor.school
University of South Australia. School of Pharmacy and Medical Sciences.
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bala, Vaskor

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/11541.2/123748

Chain of custody

source
Harvested from
University of Adelaide
Base URL
digital.library.adelaide.edu.au/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Bala, Vaskor. A combined lipophilic prodrug and lipid-based drug delivery approach to enable oral chemotherapy (with SN38). 2016. https://hdl.handle.net/11541.2/123748